Article Details

Kinnate, OrbiMed team up to target Chinese lung cancer market

Retrieved on: 2021-05-14 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Kinnate, OrbiMed team up to target Chinese lung cancer market. View article details on hiswai:

Excerpt

Kinnate Biopharma and investors including OrbiMed Asia Partners have created a Chinese joint venture. The new company will develop Kinnate's ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up